Specialized Medical Company (4019.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Specialized Medical Company — annual and quarterly history.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | 247↑902.9% | 25↑93.2% | 13↑119.9% | 6↑69.8% | 3 | |
| Short-Term Investments | 3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash & Short-Term Investments | 249↑914.1% | 25↑93.2% | 13↑119.9% | 6↑69.8% | 3 | |
| Net Receivables | 465↑313.2% | 113↓17.5% | 137↑19.6% | 114↑24.4% | 92 | |
| Accounts Receivable | 459↑317.1% | 110↓18.7% | 135↑19.7% | 113↑24.8% | 91 | |
| Other Receivables | 6↑141.3% | 3↑110.9% | 1↑8.8% | 1↓5.2% | 1 | |
| Inventory | 27↑127.2% | 12↑47.9% | 8↑39.2% | 6↑5.2% | 6 | |
| Prepaid Assets | 39↑602.6% | 6↑268.5% | 2↑132.8% | 0.65↑22.7% | 0.53 | |
| Other Current Assets | 4↑1442.6% | 0.26↓95.5% | 6↑11.0% | 5↓91.3% | 60 | |
| Total Current Assets | 785↑406.5% | 155↓5.9% | 165↑25.1% | 132↓18.2% | 161 | |
| Property, Plant & Equipment | 1,515↑289.8% | 389↑0.2% | 388↑4.8% | 370↑12.9% | 328 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Goodwill & Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 100 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 1,615↑315.6% | 389↑0.2% | 388↑4.8% | 370↑12.9% | 328 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 2,400↑341.5% | 544↓1.6% | 552↑10.1% | 502↑2.6% | 489 | |
| Liabilities | ||||||
| Total Payables | 125↑318.8% | 30↓6.7% | 32↑6.2% | 30↑21.1% | 25 | |
| Accounts Payable | 115↑316.9% | 28↓9.3% | 31↑4.8% | 29↑21.2% | 24 | |
| Other Payables | 10↑342.9% | 2↑46.0% | 2↑44.7% | 1↑19.0% | 0.88 | |
| Accrued Expenses | 0.00↓100.0% | 14↑9.0% | 13↑13.7% | 11↓1.0% | 11 | |
| Short-Term Debt | 304↑100.0% | 152↑14.7% | 133↑9.3% | 121↑21.0% | 100 | |
| Current Lease Obligations | 40 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax Payables | 26 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Revenue | 0.00↓100.0% | 3↓10.9% | 3↓1.2% | 3↑30.1% | 2 | |
| Other Current Liabilities | 83↑1284.2% | 6↓33.7% | 9↑27.5% | 7↑31.8% | 5 | |
| Total Current Liabilities | 552↑170.1% | 204↑8.0% | 189↑9.6% | 173↑19.8% | 144 | |
| Long-Term Debt | 229↑198.3% | 77↓19.7% | 95↑2.3% | 93↓24.1% | 123 | |
| Non-Current Lease Obligations | 254↑372.1% | 54↓6.1% | 57↑41.2% | 41↓15.2% | 48 | |
| Non-Current Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 178↑1685.4% | -11↑23.8% | -15↓3884.8% | 0.39↑104.6% | -8 | |
| Total Non-Current Liabilities | 660↑453.6% | 119↓13.6% | 138↑2.8% | 134↓17.3% | 162 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 293↑445.9% | 54↓6.1% | 57↑41.2% | 41↓15.2% | 48 | |
| Total Liabilities | 1,212↑274.5% | 324↓1.1% | 327↑6.6% | 307↑0.2% | 306 | |
| Equity | ||||||
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock | 250↑276.0% | 66↑193.8% | 23↑0.2% | 23↓0.1% | 23 | |
| Retained Earnings | 888↑533.2% | 140↓25.8% | 189↑19.2% | 159↑8.5% | 146 | |
| Additional Paid-In Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | 50↑276.0% | 13↓0.1% | 13↑0.2% | 13↓0.1% | 13 | |
| Other Stockholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Stockholders' Equity | 1,188↑440.0% | 220↓2.2% | 225↑15.7% | 195↑6.8% | 182 | |
| Total Equity | 1,188↑440.0% | 220↓2.2% | 225↑15.7% | 195↑6.8% | 182 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities & Equity | 2,400↑341.5% | 544↓1.6% | 552↑10.1% | 502↑2.6% | 489 | |
| Balance Sheet Summary | ||||||
| Total Investments | 103 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Debt | 826↑192.5% | 282↓1.0% | 285↑11.8% | 255↓5.9% | 271 | |
| Net Debt | 579↑124.7% | 258↓5.4% | 272↑9.3% | 249↓6.8% | 268 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.